Drug Trial Radar · NCT02718261
Sup-Icu RENal (SIREN)
Last checked: Nov 19, 2026Latest source record: Sep 11, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,350
Actual
Start
Feb 2016
Primary completion
Sep 2018
Study completion Sep 2018
Sponsor
- Lead sponsor
- Insel Gruppe AG, University Hospital BernAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Copenhagen University Hospital, Rigshospitalet
- First posted
- Mar 24, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Data show that episodes of bleeding may often be observed in critically ill patients with dialysis-dependent acute renal failure (ARF) on renal replacement therapy (RRT). From a clinical perspective, patients with dialysis-dependent ARF and end-stage renal disease (ESRD) may be considered a high risk population in regard to e.g. development of gastrointestinal (GI-) bleeding. In the current prospective subanalysis "SIREN" of the randomized placebo-controlled clinical trial "SUP-ICU" (NCT02467621), the investigators seek to elucidate whether the subpopulation of critically ill patients with acute kidney injury requiring renal replacement therapy (RRT) benefit from prophylactic treatment with a proton-pump-inhibitor such as pantoprazole.
Conditions
- Critical Illness
- Acute Kidney Injury
- End-stage Renal Disease
- Renal Replacement Therapy
- Proton Pump Inhibitor
Interventions
PantoprazoleDrug
Saline 0.9% (matching placebo)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of patients with clinically important GI bleedingTime frame: 90 days or length of ICU stay, as applicable
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Rigshospitalet
Copenhagen, Denmark
Dept. of Intensive Care Medicine, University of Bern,
Bern, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.